| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| UNI - EN REPORT No | 27 | / | 2020 | ||||||||
| Date of issue: | 2020-07-30 | ||||||||||
| Short name of the issuer | |||||||||||
| KRKA | |||||||||||
| Subject | |||||||||||
| Unaudited Interim Report of the Krka Group and Krka, d. d. for the Half Year Ended 30 June 2020 | |||||||||||
| Official market - legal basis | |||||||||||
| art. 56. 1. 2 of Act on Public Offering. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Please find the Unaudited Interim Report of the Krka Group and Krka, d. d. for the Half Year Ended 30 June 2020 and the Press release in the attachments. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Unaudited Interim Report of the Krka Group and Krka, d. d. for the Half Year Ended 30 June 2020.pdf | Unaudited Interim Report of the Krka Group and Krka, d. d. for the Half Year Ended 30 June 2020 | ||||||||||
| Press release.pdf | Press release | ||||||||||
| KRKA, TOVARNA ZDRAVIL D.D. | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| KRKA | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 8501 | Nove Mesto | ||||||||||||
| (post code) | (city) | ||||||||||||
| Smarjeska | 6 | ||||||||||||
| (street) | (number) | ||||||||||||
| +386 7 331 21 11 | +386 7 332 15 37 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nie dotyczy | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2020-07-30 | Jože Colarič | President of the Managemen Board | |||
Unaudited Interim Report of the Krka Group and Krka, d. d. for the Half Year Ended 30 June 2020.pdf
Press release.pdf
